Webster Bank N. A. Decreases Position in iShares Biotechnology ETF (NASDAQ:IBB)

Posted by Alphonse Anthony on Jan 27th, 2025

Webster Bank N. A. decreased its position in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 9.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 6,414 shares of the financial services provider’s stock after selling 650 shares during the period. Webster Bank N. A.’s holdings in iShares Biotechnology ETF were worth $848,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Darwin Wealth Management LLC bought a new position in shares of iShares Biotechnology ETF during the 3rd quarter worth $29,000. Highline Wealth Partners LLC purchased a new stake in iShares Biotechnology ETF during the third quarter valued at about $30,000. Ashton Thomas Securities LLC bought a new position in iShares Biotechnology ETF during the third quarter worth about $36,000. Modus Advisors LLC purchased a new position in shares of iShares Biotechnology ETF in the fourth quarter worth about $41,000. Finally, Voisard Asset Management Group Inc. bought a new stake in shares of iShares Biotechnology ETF in the third quarter valued at approximately $59,000. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Down 0.7 %

IBB opened at $137.30 on Monday. iShares Biotechnology ETF has a 12 month low of $123.60 and a 12 month high of $150.57. The company has a 50 day moving average of $136.04 and a 200 day moving average of $141.81.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were issued a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Profile

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.